ZBH
45
-24
OKE
55
3
O
60
-6
TSN
48
-14
ED
55
2
VRTX
56
-14
XRX
34
-22
V
34
-36
PG
41
3
KMI
73
6
M
59
-3
LRCX
71
-3
BXP
30
-3
WMT
59
-16
EMC
74
5
EXR
37
-14
URI
62
-13
MOS
52
3
DGX
43
-4
UNM
50
-20
ZBH
45
-24
OKE
55
3
O
60
-6
TSN
48
-14
ED
55
2
VRTX
56
-14
XRX
34
-22
V
34
-36
PG
41
3
KMI
73
6
M
59
-3
LRCX
71
-3
BXP
30
-3
WMT
59
-16
EMC
74
5
EXR
37
-14
URI
62
-13
MOS
52
3
DGX
43
-4
UNM
50
-20
Financhill
Back

Perspective Therapeutics, Inc. Stock Predictions

Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.

Stop trusting exchanges. Learn how to access Native Markets where YOU control your assets
Sell
37

CATX
Perspective Therapeutics, Inc.

Last Price:
$2.7000
Seasonality Move:
6.73%

7 Day Trial

ALL ACCESS PASS

$ 7

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Perspective Therapeutics, Inc. Stock Forecast

  • Is Perspective Therapeutics, Inc. Stock Undervalued?
    The current Perspective Therapeutics, Inc. [CATX] share price is $2.6700. The Score for CATX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Perspective Therapeutics, Inc. Stock Go Up Next Year?

Data Unavailable

Perspective Therapeutics, Inc. Stock Rating

Data Unavailable

Perspective Therapeutics, Inc. Stock Price History

Is CATX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CATX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
perspectivetherapeutics.com

52-Week Data

52-Week High:
5.3881
52-Week Low:
1.6000

Prediction Charts

Market Cap:
200M
Price in USD:
2.6700
Volume:
1.2M
Beta:
-73.5089

Technical Analysis

SMA50:
2.4894
SMA100:
2.9288
SMA200:
3.0434
52-Wk Change:
-25.83%

Stock Predictions

  • Is Perspective Therapeutics, Inc. stock public?
    Yes, Perspective Therapeutics, Inc. is a publicly traded company.
  • What is the Perspective Therapeutics, Inc. stock quote today?
    The Perspective Therapeutics, Inc. stock price is 2.6700 USD today.
  • How to buy Perspective Therapeutics, Inc. stock online?
    You can buy Perspective Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jan-2 2.7500 2.7900 2.8200 2.7100
Jan-5 2.8000 2.7300 2.8000 2.6450
Jan-6 2.7000 2.8100 2.8500 2.6900
Jan-7 2.8400 2.8700 2.9600 2.7400
Jan-8 2.8600 2.8100 2.8893 2.7100
Jan-9 2.8100 2.8400 2.9550 2.6500
Jan-12 2.8800 2.4100 2.8900 2.3250
Jan-13 2.4400 2.5100 2.6399 2.3700
Jan-14 2.5500 2.6200 2.6600 2.5100
Jan-15 2.6100 2.4800 2.6250 2.4500
Jan-16 2.4600 2.3300 2.4702 2.3200
Jan-20 2.3000 2.4300 2.4550 2.2500
Jan-21 2.4400 2.5500 2.5776 2.4100
Jan-22 2.5600 2.6700 2.7300 2.5300

Perspective Therapeutics, Inc. Earnings

Data Unavailable

Perspective Therapeutics, Inc. Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.14 per share, and an increase next year of $0.17 per share.

* Perspective Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.